Skip to content
PubMed This is a summary of 16 peer-reviewed journal articles Updated
Dermatology

Clinical Patterns and Associated Conditions

At a Glance

Pyoderma gangrenosum has four skin patterns: classic ulcerative, bullous, pustular, and vegetative. Some patterns are associated with bowel disease, arthritis, or blood disorders, but a skin pattern alone does not prove another condition; evaluation uses symptoms, an exam, and routine tests.

While Pyoderma Gangrenosum (PG) is often first noticed as a painful skin lesion, it is frequently a “window” into what is happening inside the rest of your body. Research shows that approximately 57% of people diagnosed with PG have an associated systemic (body-wide) medical condition [1]. Understanding the specific way your PG appears can help your care team identify whether another health issue needs attention. However, it is important to remember that these are associations, not proof of causation. An association with PG does not mean a patient definitely has leukemia, MDS, IBD, or arthritis. Evaluation is tailored to symptoms, examination, age, and routine laboratory findings, and many patients have no identified associated disease.

The Four Major Patterns

Dermatologists categorize PG into four main clinical subtypes based on how the lesions look and behave. While they all involve immune system overactivity, they can signal different things about your overall health. Subtypes can overlap, but identifying the primary pattern is helpful.

  1. Classic Ulcerative PG: This is the most common form. It typically begins as a small, painful red bump or blood-filled blister that rapidly breaks down into a deep ulcer [2]. These ulcers often have “undermined” edges—meaning the wound is larger underneath the surface than it appears from above—and a distinct purple or violet border [3]. It most often appears on the legs but can occur anywhere [4].
  2. Bullous (Atypical) PG: This subtype is characterized by the rapid appearance of painful, blue-gray blisters (bullae) [5]. It tends to be shallower than the classic ulcerative type but can spread quickly [6].
  3. Pustular PG: This version presents as clusters of small, pus-filled bumps (pustules) that do not contain bacteria [7]. It is often associated with intense inflammation and may stay as pustules for a long time before potentially turning into ulcers [8].
  4. Vegetative (Superficial Granulomatous) PG: This is a milder, slower-growing version. The lesions are usually less painful and more superficial, appearing as firm, crusty plaques rather than deep holes [9]. Unlike the other types, this form is only rarely linked to other internal diseases [10].

The Connection to Systemic Health

Because PG is an inflammatory disorder, it may be associated with other conditions that cause high levels of inflammation in the body.

Inflammatory Bowel Disease (IBD)

There is a strong link between PG and digestive health. Roughly 18% to 41% of patients with PG also have Crohn’s disease or ulcerative colitis, though estimates depend on the cohort studied [1][11]. In children, this connection is even stronger; one study found that over half of pediatric PG patients had Crohn’s disease [12]. Pustular PG, in particular, is frequently seen in people experiencing a “flare” of their bowel disease [12].

Inflammatory Arthritis

Joint issues are another common companion to PG, affecting about 13% to 20% of patients [1][11]. Interestingly, joint symptoms like stiffness and swelling often appear long before the skin lesions do—sometimes by a median of 10 years [13]. Rheumatoid arthritis is the most frequent association in this category [13].

Hematologic (Blood) Disorders

The bullous (blistered) subtype of PG carries a specific and important association with blood disorders, particularly myelodysplastic syndrome (MDS) and certain types of leukemia [5][14]. In these cases, the skin reaction may be an early sign of a bone marrow issue [15]. A bullous pattern does not definitively diagnose a blood disorder by itself, but its presence often prompts doctors to perform a more detailed blood evaluation like a CBC [6][5].

Subtype Key Feature Common Association [16][1]
Classic Deep ulcer, violet border IBD, Arthritis
Bullous Painful blue-gray blisters Blood disorders (MDS, Leukemia)
Pustular Clusters of sterile pustules IBD flares
Vegetative Shallow, crusty plaques Rarely linked to other disease

Understanding these patterns allows you and your doctor to look beyond the skin and ensure that any underlying conditions driving the inflammation are appropriately evaluated.

Common questions in this guide

What are the four clinical patterns of pyoderma gangrenosum?
The four main patterns are classic ulcerative, bullous, pustular, and vegetative, also called superficial granulomatous, pyoderma gangrenosum. They differ in whether lesions are deep ulcers, blisters, pustules, or shallower crusty plaques, and more than one pattern can occur in the same person.
Does having pyoderma gangrenosum mean I have another disease?
No. PG is associated with conditions such as inflammatory bowel disease, arthritis, and certain blood disorders, but the skin pattern alone does not prove that another disease is present. Doctors decide whether to test based on your symptoms, examination, age, and routine lab results, and many people have no identified associated condition.
Which health conditions are most often linked to PG?
PG is commonly associated with Crohn disease or ulcerative colitis, inflammatory arthritis, and some blood disorders, especially myelodysplastic syndrome and certain leukemias. The strength of the association varies by PG subtype; bullous PG is particularly linked to blood disorders, while pustular PG can occur during bowel disease flares.
Why might someone with bullous PG need a blood test?
Bullous PG can be associated with myelodysplastic syndrome and certain leukemias, sometimes before the blood disorder is recognized. This does not mean a person with bullous PG has cancer, but a clinician may recommend a complete blood count and other evaluation based on the full clinical picture.
Can joint or digestive symptoms be related to PG?
Yes. Joint stiffness, pain, or swelling and digestive problems such as Crohn disease or ulcerative colitis can occur with PG. Joint symptoms may begin years before the skin lesions, so tell your clinician about symptoms even if they started long ago.
What should I tell my doctor about a new PG lesion?
Describe whether it began as a bump, blister, or pimple-like spot, how quickly it changed, and how painful it is. Also mention digestive symptoms, joint swelling or stiffness, fatigue, easy bruising, or frequent infections, because these details can help guide evaluation.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.Which of the four clinical patterns does my skin lesion most closely match?
  2. 2.Given that more than half of people with PG have an underlying condition, what basic tests (like blood work) should we do to check for them?
  3. 3.I have a history of [joint pain/stomach issues/fatigue]; could this be linked to my skin symptoms?
  4. 4.If my lesions are the bullous (blistered) type, should I have a CBC or see a hematologist for a specialized blood evaluation?
  5. 5.Does the timing of my symptoms suggest that one condition might be related to the other?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (16)
  1. 1

    Underlying Systemic Diseases in Pyoderma Gangrenosum: A Systematic Review and Meta-Analysis.

    Kridin K, Cohen AD, Amber KT

    American journal of clinical dermatology 2018; (19(4)):479-487 doi:10.1007/s40257-018-0356-7.

    PMID: 29721816
  2. 2

    Pyoderma gangrenosum - a guide to diagnosis and management .

    George C, Deroide F, Rustin M

    Clinical medicine (London, England) 2019; (19(3)):224-228 doi:10.7861/clinmedicine.19-3-224.

    PMID: 31092515
  3. 3

    Diagnostic Criteria of Ulcerative Pyoderma Gangrenosum: A Delphi Consensus of International Experts.

    Maverakis E, Ma C, Shinkai K, et al.

    JAMA dermatology 2018; (154(4)):461-466 doi:10.1001/jamadermatol.2017.5980.

    PMID: 29450466
  4. 4

    Pyoderma Gangrenosum: A Critical Appraisal.

    Shavit E, Alavi A, Sibbald RG

    Advances in skin & wound care 2017; (30(12)):534-542 doi:10.1097/01.ASW.0000526605.34372.9e.

    PMID: 29140836
  5. 5

    Bullous pyoderma gangrenosum as a predictor of hematological malignancies.

    Vacas AS, Bollea-Garlatti ML, Torre AC, Galimberti RL

    Anais brasileiros de dermatologia 2018; (93(1)):133-134 doi:10.1590/abd1806-4841.20187031.

    PMID: 29641716
  6. 6

    Bullous Pyoderma Gangrenosum With Subungual Involvement Associated With Ulcerative Colitis.

    Aktaş Karabay E, Aksu Cerman A, Kıvanc Altunay İ, Yalçın Ö

    The American Journal of dermatopathology 2017; (39(6)):476-478 doi:10.1097/DAD.0000000000000801.

    PMID: 27893467
  7. 7

    Decoding the Histopathology of Pustular Pyoderma Gangrenosum: A Multidisciplinary Approach to Diagnosis.

    Bavikar R, Singh D

    Cureus 2024; (16(8)):e67059 doi:10.7759/cureus.67059.

    PMID: 39286710
  8. 8

    A Case of Pustular Pyoderma Gangrenosum Misdiagnosed as Acute Febrile Neutrophilic Dermatosis in a Pediatric Patient.

    Yang X, Wu Y, Jiang F, Deng D

    Clinical, cosmetic and investigational dermatology 2024; (17()):493-498 doi:10.2147/CCID.S449404.

    PMID: 38435844
  9. 9

    A perplexing case of superficial granulomatous pyoderma with sporotrichoid-like distribution.

    Parker J, Liszewski W, Merten AH, et al.

    Dermatology online journal 2020; (26(6)).

    PMID: 32815693
  10. 10

    Superficial Granulomatous Pyoderma Successfully Treated with Intravenous Immunoglobulin.

    Borg Grech S, Vella Baldacchino A, Corso R, et al.

    European journal of case reports in internal medicine 2021; (8(9)):002656 doi:10.12890/2021_002656.

    PMID: 34671571
  11. 11

    The Association of Age With Clinical Presentation and Comorbidities of Pyoderma Gangrenosum.

    Ashchyan HJ, Butler DC, Nelson CA, et al.

    JAMA dermatology 2018; (154(4)):409-413 doi:10.1001/jamadermatol.2017.5978.

    PMID: 29450453
  12. 12

    Pediatric Pyoderma Gangrenosum: A Retrospective Review of Clinical Features, Etiologic Associations, and Treatment.

    Schoch JJ, Tolkachjov SN, Cappel JA, et al.

    Pediatric dermatology 2017; (34(1)):39-45 doi:10.1111/pde.12990.

    PMID: 27699861
  13. 13

    Inflammatory arthritis-associated pyoderma gangrenosum: a systematic review.

    Sawka E, Zhou A, Latour E, et al.

    Clinical rheumatology 2021; (40(10)):3963-3969 doi:10.1007/s10067-021-05768-7.

    PMID: 34002351
  14. 14

    Pyoderma gangrenosum in hematologic malignancies: A systematic review.

    Montagnon CM, Fracica EA, Patel AA, et al.

    Journal of the American Academy of Dermatology 2020; (82(6)):1346-1359 doi:10.1016/j.jaad.2019.09.032.

    PMID: 31560977
  15. 15

    Bullous Variant of Pyoderma Gangrenosum in a Patient with Acute Myeloid Leukemia.

    Kwon CI, Lee GW, Kim CY

    Annals of dermatology 2022; (34(3)):212-215 doi:10.5021/ad.2022.34.3.212.

    PMID: 35721340
  16. 16

    Management of Idiopathic Pyoderma Gangrenosum With Azathioprine As the Primary Adjunct in an Asian Man: A Case Report.

    Nazir A, Zafar A

    Cureus 2022; (14(5)):e25177 doi:10.7759/cureus.25177.

    PMID: 35746991

This page is for informational purposes only and does not constitute medical advice. A dermatologist or other clinician should interpret your symptoms and decide whether testing for an associated condition is appropriate.

Get notified when new evidence is published on Pyoderma gangrenosum.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.